Mobius Therapeutics' Series B Round

Mobius Therapeutics raised a round of funding on October 11, 2013. Investors include Cultivation Capital.

Mobius Therapeutics is a commercial stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corne…

Articles about Mobius Therapeutics' Series B Round: